NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|24650885|ref|NP_651643|]
View 

Neprilysin-like 18 [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
58-679 2.70e-152

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 455.67  E-value: 2.70e-152
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885  58 VSPCDDFYTHACGNWHRHNPAQLlGDVMTDNFKLISKGFDRRLQRLLRANDLQ---SELEKKMQRFYMSCNLVHRDDVHY 134
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPA-DKSSWGSFSELQDRNEEQLREILEEAASSaadSSAEQKAKDFYKSCMDEEAIEKLG 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 135 KLALENVIREYGtlpalvgaQWNSSDFSWWRTVAQIQHKYGKQIIIGLEIMHDIRNTSVNRVYISQPDFK------TINT 208
Cdd:cd08662  80 LKPLKPLLDKIG--------GLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGlpdrdyYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 209 RLTNLMEEVRTSM-DLQQYFGLSSSVAKHTAEQLTELERTFSSGGSGAATLQESLSLY---TVADLQEKYSdHLNFTEFL 284
Cdd:cd08662 152 ENAEIREAYKKYIaKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYnplTLAELQKLAP-SIDWKAYL 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 285 GLILGEENIPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA------------QPKDMVKWC 345
Cdd:cd08662 231 KALGPPADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLapylskeFRDArffygkalsgqkEPEPRWKRC 310
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 346 TESTKKYFGKLAEHAVYKRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISNATRTLAIEKLERMHLNI----NSYDE 421
Cdd:cd08662 311 VELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERL--ENLDWMDEETKKKALEKLDAMKVKIgypdKWRDY 388
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 422 ENFENVYGEVFIDRlNYVSNVQQLLIAKGIRFVARINQPadsVDATELlGFTPA-----YNIQENNITIPVALLQPRyFW 496
Cdd:cd08662 389 SALDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKP---VDRTEW-SMSPQtvnayYNPSLNEIVFPAGILQPP-FF 462
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 497 GDQYPEALKYATLGYLLAHEMLHGFDDDGRQYDASGNLAPWWDLKSRYEFEERRKCFQAQYHEYQY-GGSKLPESKDQSE 575
Cdd:cd08662 463 DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVpPGLHVNGKLTLGE 542
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 576 NIADSGGLKLAYAAYELWLGQQSEEVLqretmEGLPFNSRQLFFLGYAQLLCDDVQFLFQPWVSQSDRHAPSKYRVIGPL 655
Cdd:cd08662 543 NIADNGGLRLAYRAYKKWLKENGPELP-----GLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPL 617
                       650       660
                ....*....|....*....|....
gi 24650885 656 SNFQEFPWVFNCSQSAPMDPEYKC 679
Cdd:cd08662 618 SNSPEFAEAFNCPPGSPMNPEKKC 641
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
58-679 2.70e-152

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 455.67  E-value: 2.70e-152
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885  58 VSPCDDFYTHACGNWHRHNPAQLlGDVMTDNFKLISKGFDRRLQRLLRANDLQ---SELEKKMQRFYMSCNLVHRDDVHY 134
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPA-DKSSWGSFSELQDRNEEQLREILEEAASSaadSSAEQKAKDFYKSCMDEEAIEKLG 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 135 KLALENVIREYGtlpalvgaQWNSSDFSWWRTVAQIQHKYGKQIIIGLEIMHDIRNTSVNRVYISQPDFK------TINT 208
Cdd:cd08662  80 LKPLKPLLDKIG--------GLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGlpdrdyYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 209 RLTNLMEEVRTSM-DLQQYFGLSSSVAKHTAEQLTELERTFSSGGSGAATLQESLSLY---TVADLQEKYSdHLNFTEFL 284
Cdd:cd08662 152 ENAEIREAYKKYIaKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYnplTLAELQKLAP-SIDWKAYL 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 285 GLILGEENIPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA------------QPKDMVKWC 345
Cdd:cd08662 231 KALGPPADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLapylskeFRDArffygkalsgqkEPEPRWKRC 310
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 346 TESTKKYFGKLAEHAVYKRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISNATRTLAIEKLERMHLNI----NSYDE 421
Cdd:cd08662 311 VELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERL--ENLDWMDEETKKKALEKLDAMKVKIgypdKWRDY 388
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 422 ENFENVYGEVFIDRlNYVSNVQQLLIAKGIRFVARINQPadsVDATELlGFTPA-----YNIQENNITIPVALLQPRyFW 496
Cdd:cd08662 389 SALDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKP---VDRTEW-SMSPQtvnayYNPSLNEIVFPAGILQPP-FF 462
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 497 GDQYPEALKYATLGYLLAHEMLHGFDDDGRQYDASGNLAPWWDLKSRYEFEERRKCFQAQYHEYQY-GGSKLPESKDQSE 575
Cdd:cd08662 463 DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVpPGLHVNGKLTLGE 542
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 576 NIADSGGLKLAYAAYELWLGQQSEEVLqretmEGLPFNSRQLFFLGYAQLLCDDVQFLFQPWVSQSDRHAPSKYRVIGPL 655
Cdd:cd08662 543 NIADNGGLRLAYRAYKKWLKENGPELP-----GLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPL 617
                       650       660
                ....*....|....*....|....
gi 24650885 656 SNFQEFPWVFNCSQSAPMDPEYKC 679
Cdd:cd08662 618 SNSPEFAEAFNCPPGSPMNPEKKC 641
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
54-681 7.06e-69

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 237.74  E-value: 7.06e-69
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885  54 MKPEVSPCDDFYTHACGNWHRHNPaqLLGD-VMTDNFKLISKGFDRRLQRLL----RANDLQSELEKKMQRFYMSC-NLV 127
Cdd:COG3590  33 MDTSVRPGDDFYRYVNGGWLKTTP--IPADrSRWGSFNELRERNEARLRAILeeaaAAPAAAGSDEQKIGDLYASFmDEA 110
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 128 HRDdvhyKLALE------NVIREYGTLPALVgaqwnssdfswwRTVAQiQHKYGKQIIIGLEIMHDIRNTSVNRVYISQ- 200
Cdd:COG3590 111 AIE----ALGLAplkpdlARIDAIKDKADLA------------ALLAA-LHRAGVGGLFGFGVDADLKNSTRYIAYLGQg 173
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 201 ----PD----FKTINTrltnlMEEVRTSM-----DLQQYFGLSSSVAKHTAEQLTELERTFSSGGSGAATLQESLSLY-- 265
Cdd:COG3590 174 glglPDrdyyLKDDEK-----SAEIRAAYvahvaKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELRDPEKTYnp 248
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 266 -TVADLQEKYSdHLNFTEFL-GLILGEeniPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA 336
Cdd:COG3590 249 mTVAELAKLAP-GFDWDAYLkALGLPA---VDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAapylskaFVDA 324
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 337 -----------QPKDMVKW--CTESTKKYFGklaeHAV---Y-KRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISN 399
Cdd:COG3590 325 nfdfygktlsgQKEQRPRWkrAVALVNGALG----EALgqlYvERYFPPEAKARMEELVANLRAAYRERI--ENLDWMSP 398
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 400 ATRTLAIEKLERMHLNInSYDEEnFENvYGEVFIDRLNYVSNVQQLLIAKGIRFVARINQPadsVDATELlGFTP----- 474
Cdd:COG3590 399 ETKAKALEKLAAFTPKI-GYPDK-WRD-YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKP---VDRTEW-GMTPqtvna 471
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 475 AYNIQENNITIPVALLQPRYFWGDQyPEALKYATLGYLLAHEMLHGFDDDGRQYDASGNLAPWWDLKSRYEFEERRKCFQ 554
Cdd:COG3590 472 YYNPTMNEIVFPAAILQPPFFDPKA-DDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLV 550
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 555 AQYHEYQYggskLPESKDQ-----SENIADSGGLKLAYAAYELWLGQQSEEVLqretmEGlpFNSRQLFFLGYAQLlcdd 629
Cdd:COG3590 551 AQYDAYEP----LPGLHVNgkltlGENIADLGGLSIAYDAYKLSLKGKEAPVI-----DG--FTGDQRFFLGWAQV---- 615
                       650       660       670       680       690       700
                ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 24650885 630 vqflfqpWVS-----------QSDRHAPSKYRVIGPLSNFQEFPWVFNCSQSAPM--DPEYKCAI 681
Cdd:COG3590 616 -------WRSkardealrqrlATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRI 673
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
60-416 4.01e-52

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 184.81  E-value: 4.01e-52
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885    60 PCDDFYTHACGNWHRHNPAQLlGDVMTDNFKLISKGFDRRLQRLLR---ANDLQSELEKKMQRFYMSC-NLVHRDDVHYK 135
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPA-DKSSWGTFDELRERNEKQLREILEeaaASESDPGAVEKAKDLYKSCmDTDAIEKLGLK 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   136 lALENVIREYGtlpalvGAQWNSSDFSWWRTVAQIqHKYGKQIIIGLEIMHDIRNTSVNRVYISQPDF---------KTI 206
Cdd:pfam05649  80 -PLKPLLDEIG------GPLANKDKFDLLETLAKL-RRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLglpdrdyylKDR 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   207 NTRLTNLMEEVRTSM-DLQQYFGLSSSVAKHtAEQLTELERTFSSGGSGAATLQESLSLY---TVADLQeKYSDHLNFTE 282
Cdd:pfam05649 152 DEKSAEIREAYKAYIaKLLTLLGASEEAAAL-AEEVLAFETKLAKASLSREERRDPEKTYnpmTLAELQ-KLAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   283 FLGLILGEENIPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA-----------QPKDMVKW 344
Cdd:pfam05649 230 YLNAAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLapylsdeFRDAnfefygtlsgtKQRPRWKR 309
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 24650885   345 CTESTKKYFGKLAEHAVYKRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISNATRTLAIEKLERMHLNI 416
Cdd:pfam05649 310 CVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERL--DELDWMDEETKKKALEKLDAMTVKI 379
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
58-679 2.70e-152

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 455.67  E-value: 2.70e-152
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885  58 VSPCDDFYTHACGNWHRHNPAQLlGDVMTDNFKLISKGFDRRLQRLLRANDLQ---SELEKKMQRFYMSCNLVHRDDVHY 134
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPA-DKSSWGSFSELQDRNEEQLREILEEAASSaadSSAEQKAKDFYKSCMDEEAIEKLG 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 135 KLALENVIREYGtlpalvgaQWNSSDFSWWRTVAQIQHKYGKQIIIGLEIMHDIRNTSVNRVYISQPDFK------TINT 208
Cdd:cd08662  80 LKPLKPLLDKIG--------GLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGlpdrdyYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 209 RLTNLMEEVRTSM-DLQQYFGLSSSVAKHTAEQLTELERTFSSGGSGAATLQESLSLY---TVADLQEKYSdHLNFTEFL 284
Cdd:cd08662 152 ENAEIREAYKKYIaKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYnplTLAELQKLAP-SIDWKAYL 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 285 GLILGEENIPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA------------QPKDMVKWC 345
Cdd:cd08662 231 KALGPPADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLapylskeFRDArffygkalsgqkEPEPRWKRC 310
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 346 TESTKKYFGKLAEHAVYKRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISNATRTLAIEKLERMHLNI----NSYDE 421
Cdd:cd08662 311 VELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERL--ENLDWMDEETKKKALEKLDAMKVKIgypdKWRDY 388
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 422 ENFENVYGEVFIDRlNYVSNVQQLLIAKGIRFVARINQPadsVDATELlGFTPA-----YNIQENNITIPVALLQPRyFW 496
Cdd:cd08662 389 SALDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKP---VDRTEW-SMSPQtvnayYNPSLNEIVFPAGILQPP-FF 462
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 497 GDQYPEALKYATLGYLLAHEMLHGFDDDGRQYDASGNLAPWWDLKSRYEFEERRKCFQAQYHEYQY-GGSKLPESKDQSE 575
Cdd:cd08662 463 DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVpPGLHVNGKLTLGE 542
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 576 NIADSGGLKLAYAAYELWLGQQSEEVLqretmEGLPFNSRQLFFLGYAQLLCDDVQFLFQPWVSQSDRHAPSKYRVIGPL 655
Cdd:cd08662 543 NIADNGGLRLAYRAYKKWLKENGPELP-----GLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPL 617
                       650       660
                ....*....|....*....|....
gi 24650885 656 SNFQEFPWVFNCSQSAPMDPEYKC 679
Cdd:cd08662 618 SNSPEFAEAFNCPPGSPMNPEKKC 641
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
54-681 7.06e-69

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 237.74  E-value: 7.06e-69
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885  54 MKPEVSPCDDFYTHACGNWHRHNPaqLLGD-VMTDNFKLISKGFDRRLQRLL----RANDLQSELEKKMQRFYMSC-NLV 127
Cdd:COG3590  33 MDTSVRPGDDFYRYVNGGWLKTTP--IPADrSRWGSFNELRERNEARLRAILeeaaAAPAAAGSDEQKIGDLYASFmDEA 110
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 128 HRDdvhyKLALE------NVIREYGTLPALVgaqwnssdfswwRTVAQiQHKYGKQIIIGLEIMHDIRNTSVNRVYISQ- 200
Cdd:COG3590 111 AIE----ALGLAplkpdlARIDAIKDKADLA------------ALLAA-LHRAGVGGLFGFGVDADLKNSTRYIAYLGQg 173
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 201 ----PD----FKTINTrltnlMEEVRTSM-----DLQQYFGLSSSVAKHTAEQLTELERTFSSGGSGAATLQESLSLY-- 265
Cdd:COG3590 174 glglPDrdyyLKDDEK-----SAEIRAAYvahvaKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELRDPEKTYnp 248
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 266 -TVADLQEKYSdHLNFTEFL-GLILGEeniPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA 336
Cdd:COG3590 249 mTVAELAKLAP-GFDWDAYLkALGLPA---VDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAapylskaFVDA 324
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 337 -----------QPKDMVKW--CTESTKKYFGklaeHAV---Y-KRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISN 399
Cdd:COG3590 325 nfdfygktlsgQKEQRPRWkrAVALVNGALG----EALgqlYvERYFPPEAKARMEELVANLRAAYRERI--ENLDWMSP 398
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 400 ATRTLAIEKLERMHLNInSYDEEnFENvYGEVFIDRLNYVSNVQQLLIAKGIRFVARINQPadsVDATELlGFTP----- 474
Cdd:COG3590 399 ETKAKALEKLAAFTPKI-GYPDK-WRD-YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKP---VDRTEW-GMTPqtvna 471
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 475 AYNIQENNITIPVALLQPRYFWGDQyPEALKYATLGYLLAHEMLHGFDDDGRQYDASGNLAPWWDLKSRYEFEERRKCFQ 554
Cdd:COG3590 472 YYNPTMNEIVFPAAILQPPFFDPKA-DDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLV 550
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885 555 AQYHEYQYggskLPESKDQ-----SENIADSGGLKLAYAAYELWLGQQSEEVLqretmEGlpFNSRQLFFLGYAQLlcdd 629
Cdd:COG3590 551 AQYDAYEP----LPGLHVNgkltlGENIADLGGLSIAYDAYKLSLKGKEAPVI-----DG--FTGDQRFFLGWAQV---- 615
                       650       660       670       680       690       700
                ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 24650885 630 vqflfqpWVS-----------QSDRHAPSKYRVIGPLSNFQEFPWVFNCSQSAPM--DPEYKCAI 681
Cdd:COG3590 616 -------WRSkardealrqrlATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRI 673
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
60-416 4.01e-52

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 184.81  E-value: 4.01e-52
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885    60 PCDDFYTHACGNWHRHNPAQLlGDVMTDNFKLISKGFDRRLQRLLR---ANDLQSELEKKMQRFYMSC-NLVHRDDVHYK 135
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPA-DKSSWGTFDELRERNEKQLREILEeaaASESDPGAVEKAKDLYKSCmDTDAIEKLGLK 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   136 lALENVIREYGtlpalvGAQWNSSDFSWWRTVAQIqHKYGKQIIIGLEIMHDIRNTSVNRVYISQPDF---------KTI 206
Cdd:pfam05649  80 -PLKPLLDEIG------GPLANKDKFDLLETLAKL-RRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLglpdrdyylKDR 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   207 NTRLTNLMEEVRTSM-DLQQYFGLSSSVAKHtAEQLTELERTFSSGGSGAATLQESLSLY---TVADLQeKYSDHLNFTE 282
Cdd:pfam05649 152 DEKSAEIREAYKAYIaKLLTLLGASEEAAAL-AEEVLAFETKLAKASLSREERRDPEKTYnpmTLAELQ-KLAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   283 FLGLILGEENIPKSLYIYDEEYLDKALLTMRSTPLATQANYVLWKLLEDF-------LVDA-----------QPKDMVKW 344
Cdd:pfam05649 230 YLNAAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLapylsdeFRDAnfefygtlsgtKQRPRWKR 309
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 24650885   345 CTESTKKYFGKLAEHAVYKRYRNPDVESEVHKIWDQIKGIFRQRLlgDKLDWISNATRTLAIEKLERMHLNI 416
Cdd:pfam05649 310 CVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERL--DELDWMDEETKKKALEKLDAMTVKI 379
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
476-679 3.12e-51

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 176.45  E-value: 3.12e-51
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   476 YNIQENNITIPVALLQPRYFwGDQYPEALKYATLGYLLAHEMLHGFDDDGRQYDASGNLAPWWDLKSRYEFEERRKCFQA 555
Cdd:pfam01431   4 YQPNRNEIVFPAAILQPPFF-DPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCLIE 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650885   556 QYHEY--QYGGSKLPESKDQSENIADSGGLKLAYAAYELWLGQQSEEVLQRETmeglpFNSRQLFFLGYAQLLCDDVQFL 633
Cdd:pfam01431  83 QYSEYtpPDGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFEN-----LTPDQLFFRGAAQIWCMKQSPA 157
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*.
gi 24650885   634 FQPWVSQSDRHAPSKYRVIGPLSNFQEFPWVFNCSQSAPMDPEYKC 679
Cdd:pfam01431 158 EVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH